Cancer Care Ontario guidelines are based on the best evidence available from healthcare research and expert opinion. If you like, you can learn more about the different documents and tools.
See newly released guidelines and advice updates from the past 6 months on our What’s New page.
Locoregional Therapy of Locally Advanced Breast Cancer (LABC)
This guideline is intended for use by surgeons, and medical and radiation oncologists specializing in breast cancer. It is relevant to female patients with LABC.
Role of Bone-Modifying Agents in Metastatic Breast Cancer
Updated recommendations on intervals between dosing and the role of bone-modifying agents in control of bone pain for patients with bone metastases from breast cancer.
Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection
This guideline is intended for clinicians involved in the delivery of chemotherapy for colon cancer patients. It is relevant to adult patients with stage II and III colon cancer who have undergone complete resection with curative intent as primary therapy.
The Use of Systemic Treatment in the Maintenance of Patients with Non-small Cell Lung Cancer (NSCLC)
This guideline is intended for oncologists involved in the care of patients with NSCLC who require maintenance systemic treatment.
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer
This guideline is intended for radiologists, family physicians, oncologists, urological surgeons and other clinicians who provide care for patients defined by the target population.